Research suggests that modulating the GH/IGF-1 axis through secretagogue administration could support tendon repair processes, though the clinical translation is still being worked out
Helps reduce appetite Improves fullness and satiety Supports consistent weekly weight loss Clinically proven results Now with Wegovy at $199, medically supervised weight loss is finally affordable
Patients require explicit directions on storage, administration, and which adverse effects to anticipate
Zepbound (tirzepatide) is a prescription medication approved by the US Food and Drug Administration (FDA) for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition
Food and Drug Administration (FDA), and multiple state health departments
Eligibility Requirements for GLP-1RAs All patients who want to use GLP-1 medications must meet one of the following requirements: A BMI of 30 or above (obesity) A BMI of 27 or above (overweight) with a weight-related health condition such as high blood sugar levels, high blood pressure, or high blood fat levels
